InsiderSignal.AI

InsiderSignal.ai

PODD - Insulet Corp

Insider Purchase by McEvoy Ashley (Pres, CEO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

1 week ago, McEvoy Ashley, serving as Pres, CEO at Insulet Corp (PODD), purchased 4,300 shares at $239.35 per share, for a total transaction value of $1,029,205.00. Following this transaction, McEvoy Ashley now holds 13,920 shares of PODD.

This purchase represents a 45.00% increase in McEvoy Ashley's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, February 20, 2026 and publicly disclosed via SEC Form 4 filing on Monday, February 23, 2026, 3 days after the trade was made.

Insulet Corp operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

McEvoy Ashley

McEvoy Ashley

Pres, CEO

Ashley McEvoy is the President and Chief Executive Officer of Insulet Corporation (PODD), a role she has held since April 2025, succeeding Jim Hollingshead.[[1]](https://www.drugdeliverybusiness.com/ashley-mcevoy-becomes-president-ceo-insulet/)[[2]](https://www.healthquestcapital.com/people/ashley-mcevoy)[[6]](https://investors.insulet.com/leadership-governance/management/default.aspx) In this position, she leads the Acton, Massachusetts-based company, a global leader in automated insulin delivery systems like the Omnipod 5, focusing on advancing diabetes care innovation and global expansion.[[1]](https://www.drugdeliverybusiness.com/ashley-mcevoy-becomes-president-ceo-insulet/)[[3]](https://www.medtechdive.com/news/ashley-mcevoy-ceo-insulet/746509/) McEvoy brings nearly three decades of healthcare leadership experience, primarily at Johnson & Johnson from 1996 to 2023, where she most recently served as Executive Vice President and Worldwide Chairman of MedTech, overseeing 60,000 employees and over $30 billion in revenue.[[1]](https://www.drugdeliverybusiness.com/ashley-mcevoy-becomes-president-ceo-insulet/)[[2]](https://www.healthquestcapital.com/people/ashley-mcevoy)[[5]](https://us.pg.com/board-of-directors/ashley-mcevoy/) During her tenure, she tripled revenue growth from 1.5% to 7.8%, led key acquisitions totaling over $22 billion, and expanded into new markets including heart failure, vision, and robotics; prior roles included Group Chair of Vision and Diabetes Care and Worldwide President of Ethicon.[[1]](https://www.drugdeliverybusiness.com/ashley-mcevoy-becomes-president-ceo-insulet/)[[2]](https://www.healthquestcapital.com/people/ashley-mcevoy)[[3]](https://www.medtechdive.com/news/ashley-mcevoy-ceo-insulet/746509/) She currently serves as an independent director on the Procter & Gamble board and previously on the Children’s Hospital of Philadelphia Board of Trustees.[[4]](https://fintool.com/app/research/companies/PG/people/ashley-mcevoy)[[5]](https://us.pg.com/board-of-directors/ashley-mcevoy/)

View full insider profile →

Trade Price

$239.35

Quantity

4,300

Total Value

$1,029,205.00

Shares Owned

13,920

Trade Date

Friday, February 20, 2026

7 days ago

SEC Filing Date

Monday, February 23, 2026

Filed 3 days after trade

HEALTHCAREMEDICAL DEVICES

About Insulet Corp

Company Overview

No company information available
View news mentioning PODD

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4229451

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime